Literature DB >> 19151790

Molecular profile of CD34+ stem/progenitor cells according to JAK2V617F mutation status in essential thrombocythemia.

L Catani, R Zini, D Sollazzo, E Ottaviani, A M Vannucchi, S Ferrari, M Baccarani, N Vianelli, R M Lemoli, R Manfredini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19151790     DOI： 10.1038/leu.2008.357

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  8 in total

1.  Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation.

Authors:  Ashley P Ng; Maria Kauppi; Donald Metcalf; Craig D Hyland; Emma C Josefsson; Marion Lebois; Jian-Guo Zhang; Tracey M Baldwin; Ladina Di Rago; Douglas J Hilton; Warren S Alexander
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-07       Impact factor: 11.205

Review 2.  Polycythemia Vera.

Authors:  Jerry L Spivak
Journal:  Curr Treat Options Oncol       Date:  2018-03-07

Review 3.  Genomic landscape of megakaryopoiesis and platelet function defects.

Authors:  Elisa Bianchi; Ruggiero Norfo; Valentina Pennucci; Roberta Zini; Rossella Manfredini
Journal:  Blood       Date:  2016-01-19       Impact factor: 22.113

4.  Disease burden at the progenitor level is a feature of primary myelofibrosis: a multivariable analysis of 164 JAK2 V617F-positive myeloproliferative neoplasm patients.

Authors:  Brady L Stein; Donna M Williams; Ophelia Rogers; Mary Ann Isaacs; Jerry L Spivak; Alison R Moliterno
Journal:  Exp Hematol       Date:  2010-10-01       Impact factor: 3.084

5.  Transcriptional profiling of polycythemia vera identifies gene expression patterns both dependent and independent from the action of JAK2V617F.

Authors:  Windy Berkofsky-Fessler; Monica Buzzai; Marianne K-H Kim; Steven Fruchtman; Vesna Najfeld; Dong-Joon Min; Fabricio F Costa; Jared M Bischof; Marcelo B Soares; Melanie Jane McConnell; Weijia Zhang; Ross Levine; D Gary Gilliland; Raffaele Calogero; Jonathan D Licht
Journal:  Clin Cancer Res       Date:  2010-07-02       Impact factor: 12.531

6.  Early and late stage MPN patients show distinct gene expression profiles in CD34+ cells.

Authors:  Julian Baumeister; Tiago Maié; Nicolas Chatain; Lin Gan; Barbora Weinbergerova; Marcelo A S de Toledo; Jörg Eschweiler; Angela Maurer; Jiri Mayer; Blanka Kubesova; Zdenek Racil; Andreas Schuppert; Ivan Costa; Steffen Koschmieder; Tim H Brümmendorf; Deniz Gezer
Journal:  Ann Hematol       Date:  2021-08-14       Impact factor: 4.030

7.  Two clinical phenotypes in polycythemia vera.

Authors:  Jerry L Spivak; Michael Considine; Donna M Williams; Conover C Talbot; Ophelia Rogers; Alison R Moliterno; Chunfa Jie; Michael F Ochs
Journal:  N Engl J Med       Date:  2014-08-28       Impact factor: 91.245

8.  Transcriptional profiling of whole blood identifies a unique 5-gene signature for myelofibrosis and imminent myelofibrosis transformation.

Authors:  Hans Carl Hasselbalch; Vibe Skov; Thomas Stauffer Larsen; Mads Thomassen; Caroline Hasselbalch Riley; Morten K Jensen; Ole Weis Bjerrum; Torben A Kruse
Journal:  PLoS One       Date:  2014-01-13       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.